intelligence360
  • SUBSCRIBE
  • About us
  • Video News Daily
  • Contact Us
  • Search Icon

intelligence360

The Intelligent News Source

Reperio Health Closes $14M Funding Round to Bring Their At-Home Preventive Care Solution to All 50 States

Reperio Health Closes $14M Funding Round to Bring Their At-Home Preventive Care Solution to All 50 States

May 28, 2025 Craig Etkin

Company has tripled preventive care participation rates and is now expanding its AI-assisted, real-time virtual care feature nationwide.

PORTLAND, Ore.–(BUSINESS WIRE)–Reperio Health, the only provider of at-home and onsite comprehensive health screenings with instant results, announced today that it has successfully closed a $14 million funding round, led by Nashville-based Caduceus Capital Partners.

At Reperio, we’re not tinkering around the edges – we’ve created an entirely new model of virtual and preventive care that helps more people get the care they need, and we’re going to make sure it reaches as many Americans as possible.Share

Caduceus Capital Partners’ leadership of this round will help Reperio bring its proven model of convenient at-home preventive screenings with instant results and seamless on-demand virtual care nationwide. By launching innovative new partnerships with employers and health plans, Reperio will help more Americans get vital preventive health care at a crucial time, as provider access has plummeted and existing virtual health and at-home testing solutions have failed to bridge the gap. While many incumbents in the industry have attempted to retrofit older business models through methods like mergers and acquisitions to meet current consumer demands, Reperio offers consumers an unparalleled experience built from the ground up with convenience and advances in AI at the core.

This fundraise will enable Reperio to build on their successes as they scale ReperioCareTM, which now allows an end-user to engage with a clinician immediately at the conclusion of their screening, eliminating the gaps in care that result from asking people to wait for days or weeks for lab results and to then re-engage. The clinician can then review the findings and establish personalized health insights. This real-time virtual consultation following a screening is globally unique to Reperio: the at-home preventive care experience is on-demand, data-driven, and hyper-personalized to the end-user.

“Three out of every five Americans are walking around today with an undiagnosed and untreated chronic condition,” said Travis Rush, CEO and co-founder of Reperio. “That’s unsustainable for our health care system’s finances, and unacceptable for those patients and their families. At Reperio, we’re not tinkering around the edges – we’ve created an entirely new model of virtual and preventive care that helps more people get the care they need, and we’re going to make sure it reaches as many Americans as possible.”

Reperio provides each patient or member with a comprehensive at-home screening kit containing FDA-cleared, Bluetooth-connected medical devices that pair with a user-friendly mobile app. This app guides the end-user through a complete preventive care screening in the comfort of their own home. They get results instantly for blood pressure, heart rate, body mass index, relative fat mass, blood glucose, total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides. Their solution also simultaneously reduces strain on providers and the health care system at large by enabling a built-in AI-assistant to quickly analyze data, provide insights and follow-up recommendations, ultimately saving them time without sacrificing quality of care.

“When we first invested in Reperio, we were intrigued by the team’s deep commitment to consumer convenience and experience,” said Dave Vreeland, Senior Managing Partner, of Caduceus Capital Partners. “Existing at-home tests all too often rely on outdated lab-based services that come with high costs and long wait times. But with Reperio, we have seen a new dawn in the testing experience. Reperio Health’s clients have seen their participation rates in preventive screenings jump by more than 200 percent – drawing anywhere from four to eight times the return-on-investment. Reperio has delivered on their promise, proven product-market fit, and now it’s time to pour gasoline on this game-changing model as they expand their on-demand virtual visits nationwide.”

Reperio kits are sponsored by health plans and employers, usually at no cost to their members and/or employees. Reperio has perfected their client experience over more than 40 launches and thousands of screenings in just 18 months of commercialization and achieved a near-perfect renewal rate. The less-than-30-minute test has earned a 95 percent customer satisfaction rate.

To learn more about Reperio, visit www.reperiohealth.com.

ABOUT REPERIO HEALTH

Reperio Health is the only provider of at-home and onsite comprehensive health screenings with instant results. An innovation in preventive care, Reperio’s patented technology pairs a mobile app with FDA-cleared devices, bringing a consumer-grade experience to biometric screenings. Clients are empowered by metrics-driven insights and HIPAA-compliant data integration to bolster their wellness, benefits and population health management offerings. Clients working with Reperio have increased screening participation rates by more than 200 percent and achieved a 95 percent satisfaction rate, driving four to eight times the cost-savings and return-on-investment. Reperio is headquartered in Portland, OR, with partners and clients worldwide. For more information, visit www.reperiohealth.com.

Contacts

For more information:
Kala Weeks
kala.w@reperiohealth.com
440-417-2316

(c)2025 Business Wire, Inc., All rights reserved.


Venture Capital
Business Wire, Oregon, Portland, Reperio Health, Venture Capital

Post navigation

NEXT
Reconstruct Raises Strategic Investment to Accelerate its AI and ML Capabilities for Global Expansion
PREVIOUS
DaySpring Baptist Church to spend $2.8 Million to occupy 10,778 square feet of space in Waco Texas.
Comments are closed.
Subscribe for FREE!

intelligence360

intelligence360
Source: http://go.intelligence360.io/ and https://intelligence360.news/

WellTheory, the leading whole-person care platform for autoimmune disease, today announced the close of $5M in new funding and the successful rollout of its proprietary AI tools, Care Hub and Care Scribe, across its care operations. New investors Samsung Next, Opal Ventures, and Up2 Fund joined the round, with continued support from existing investors Accel, OVO Fund, and BoxGroup. WellTheory is a virtual care platform reversing the autoimmune epidemic by filling the gaps left behind in traditional healthcare. WellTheory offers a research-backed proprietary program that addresses the root cause of autoimmunity and treats the whole person with the aim to reduce symptoms, improve quality of life, and lower costs.

In a statement Ellen Rudolph, CEO and Co-founder of WellTheory said, “AI is no longer a nice-to-have in care delivery — its essential infrastructure.” “This new round of funding is allowing us to double down on our AI strategy, streamline the most time-consuming parts of care, and expand into new markets. We’re leading the charge in making whole-person, root-cause care more accessible, personalized, and effective and bringing it to scale through our growing partnerships with employers and health plans.”

WellTheory’s Care Scribe, the company’s proprietary AI assistant, now supports its Care Team by attending member sessions, transcribing conversations, and drafting follow-up notes and personalized Care Plans — all for provider review and customization. The tool has reduced provider prep and documentation time by 65%, enabling a more efficient and focused care experience. This meta-intelligence will power a more personalized, proactive experience for members, surfacing symptom patterns, optimizing interventions, and enabling the Care Team to deliver precision support at scale. By connecting the dots across a fragmented care journey, WellTheory aims to not only reduce the burden of autoimmune disease — but also to fundamentally reimagine how it’s managed.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

A growing Central Texas suburb will soon be the home of a new, massive tourist destination. Cedar Park, a city in Williamson County about 20 miles north of Austin, is getting a $95 million Marriott Hotel and Convention Center. The Cedar Park Marriott Hotel and Convention Center will be a new construction at 2155 Cedarview Drive, in Cedar Park. This landmark development will include a cutting-edge hotel with approximately 300 guest rooms, 30,000 square feet of event and meeting space, a full-service restaurant, a breakfast café, and an expansive pool area. Poised to become a focal point of Cedarview, this project will serve as a premier destination for both business and leisure travelers.

Construction on the new hotel and convention center began this May and is expected to end by February 2027. Cedar Park Marriott will be a 210,965-square-foot hotel with seven stories and 297 guest rooms connected to a 50,797-square-foot conference center. There will also be a 120,445-square-foot, three-story parking garage connected to the hotel to fit 320 slots. The project's entire construction site will cover 382,207 square feet.

Project developer Great Lakes Capital said that the hotel will also have "a full-service restaurant, a breakfast café, and an expansive pool area." This new Marriott will become one of Cedar Park’s only full-service hotels, meaning it can accommodate guests seeking on-site dining, recreation and concierge services. Great Lakes Capital is a real estate development and private equity firm uniquely positioned to add value to real estate investments through development, redevelopment and opportunistic investment across the real estate spectrum and throughout the capital structure. Headquartered in South Bend, Indiana, with over $1 billion in assets under management or development, GLC concentrates on several core asset classes, including mixed-use, multifamily, industrial, medical office and other similar conforming product types. As a market leader in new development, GLC actively addresses the needs of tenant partners in addition to speculative development meeting needs the market has not yet reacted to. Luminaut in Cincinnati is listed as the design firm on the project.
Source: http://go.intelligence360.io/ and https://intelligence360.news/

Acrisure has announced it has entered into a definitive agreement for the issuance of new convertible senior preferred stock in a $2.1 billion capital raise led by Bain Capital. Funds from the round will be used to refinance a portion of its existing non-convertible preferred stock, pursue strategic accretive M&A and accelerate its development as a tech-enabled financial services platform, advancing its strategy to become the preeminent fintech solutions provider for millions of small- and medium-sized businesses domestically and abroad. The investors involved in the transaction include Bain Capital Special Situations, Fidelity Management & Research Company, Apollo Funds, Gallatin Point Capital, BDT & MSD Partners, and a consortium of other investors. No existing investor exited as part of this transaction. BDT & MSD remains the largest minority shareholder in Acrisure through affiliated funds.

In a statement Greg Williams, Chairman, CEO and Co-founder of Acrisure said, “This transaction represents a significant milestone and serves as proof that our vision for Acrisure’s scaled platform has become a reality.” “Our evolution from an insurance brokerage into an AI- and technology-powered global financial services provider has opened the door to massive opportunity. I see limitless potential for how far Acrisure can go, and we’re extremely grateful for the financial support and validation from our investors.”

Going forward, Acrisure will continue to expand its footprint and product offerings through strategic, accretive M&A, fully integrating the platform created through its previous 900 acquisitions, and driving organic growth with its robust suite of tailored offerings, which now includes real estate services, cybersecurity tools, payroll and payment processing, and retirement and wealth solutions. Acrisure’s unprecedented growth has driven the company’s valuation to $32 Billion, marking a nearly 40% increase since its last institutional capital raise just three years ago. A global fintech leader, Acrisure empowers millions of ambitious businesses and individuals with the right solutions to grow boldly forward. Bringing cutting-edge technology and top-tier human support together, it connects clients with customized solutions across a range of insurance, reinsurance, payroll, benefits, cybersecurity, real estate services – and beyond. In the last eleven years, Acrisure has grown in revenue from $38 million to almost $5 billion and employs over 19,000 colleagues in 23 countries.
Load More... Subscribe

Categories

Recent Posts

  • Solana Capital Group to spend $5.5 Million to occupy 58,700 square feet of space in Balch Springs Texas. May 30, 2025
  • Shift to spend $2 Million to occupy 53,000 square feet of space in Dallas Texas. May 30, 2025
  • Sellmark Corporation to spend $23,230,000.00 to occupy 169,590 square feet of space in Mansfield Texas. May 30, 2025
  • Barndoor AI Raises $13.6M in Series Seed to Deliver the First Control Plane for Agentic AI Workforces May 30, 2025

Archives

© 2025   Copyright SI360 Inc. All Rights Reserved.